2019 Access Programs Treatment 
The Cannigma
AUGUST 5, 2022
Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.
Veriheal
FEBRUARY 21, 2023
As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
SEPTEMBER 15, 2023
All eyes are on Georgia’s medical cannabis program as it continues to grow. The History of the Georgia Medical Cannabis Program Georgia’s medical cannabis program started sales this past spring. In April 2019, House Bill 324 was approved, enabling in-state cultivation and the sale of low-THC oil.
Veriheal
NOVEMBER 11, 2021
Before Proposition 64 was officially enacted into state law, California’s medical cannabis consumers were generously served by a range of successful and well-executed compassionate care programs. Gavin Newsom in October 2019. A Collaborative Effort To Increase Cannabis Access. Scott Wiener, who sponsored SB 34.
Veriheal
MAY 31, 2022
opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. A 2019 study found that 76% of patients in the U.S. Vital Changes to Texas’ Medical Cannabis Program.
NORML
JULY 1, 2019
Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “This year, my focus was on program improvements to further expand both access and therapeutic value to benefit the health and well-being of all Virginians.”
Veriheal
MAY 11, 2023
In 2015, Texas passed the Compassionate Use Act, which allowed patients with intractable epilepsy to access low-THC cannabis oil containing no more than 0.5% In 2019, the program was expanded to include patients with other qualifying conditions, such as terminal cancer, autism, multiple sclerosis, and certain neurological disorders.
Expert insights. Personalized for you.
138 
Let's personalize your content